Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening

Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. There have been very few developments in its diagnosis and treatment over the past decades. It is urgently needed to explore potential novel biomarkers and drug targets for SCLC. Methods: Two-sample Men...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yijun, Wang, Zhile, Yang, Yuqi, Han, Chang, Wang, Li, Kang, Kai, Zhao, Ailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511877/
https://www.ncbi.nlm.nih.gov/pubmed/37745050
http://dx.doi.org/10.3389/fphar.2023.1266782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511877/
https://www.ncbi.nlm.nih.gov/pubmed/37745050
http://dx.doi.org/10.3389/fphar.2023.1266782

Ejemplares similares